DC Chemicals · Research reagents

Small Molecule Research Tools

Explore 56 research products with specifications, prices and referenced biological activity.

NCT-503 chemical structureDC10486

NCT-503

NCT-503 is a PHGDH inhibitor for studying serine synthesis, one-carbon metabolism and metabolic dependencies in cancer models. Published studies distinguish biochemical inhibition from cellular growth effects and document context-dependent off-target activity.

View activity & prices
WM-1119 chemical structureDC10881

WM-1119

WM-1119 is a KAT6A/KAT6B inhibitor for epigenetic and cellular-senescence research. The primary study reports binding selectivity, lymphoma-cell growth inhibition and suppression of lymphoma progression in mice.

View activity & prices
CD38 inhibitor 78c chemical structureDC20332

CD38 inhibitor 78c

CD38 inhibitor 78c is a reversible CD38 NADase inhibitor for NAD+ metabolism and aging research. Published work links CD38 inhibition to cellular NAD+ elevation and functional changes in mouse aging models.

View activity & prices
ARV-771 chemical structureDC10334

ARV-771

ARV-771 is a VHL-recruiting BET protein degrader for prostate cancer and targeted protein degradation research. The primary study reports pan-BET degradation, downstream c-MYC suppression and activity in prostate cancer models.

View activity & prices
WM-8014 chemical structureDC10880

WM-8014

WM-8014 is a KAT6A/KAT6B inhibitor for chromatin, cellular senescence and cancer research. Published work separates biochemical inhibition, fibroblast growth arrest and responses in a zebrafish liver cancer model.

View activity & prices
KPT-6566 chemical structureDC11276

KPT-6566

KPT-6566 is a covalent PIN1 inhibitor for cancer signaling research. Published studies connect PIN1 inhibition with oxidative stress, DNA damage, cancer-cell death and reduced lung colonization in mice.

View activity & prices
Laropiprant chemical structureDC1009

Laropiprant

Laropiprant is a DP1 receptor antagonist for prostanoid signaling and platelet-function research. Its effects on platelet activation vary with agonist and concentration.

View activity & prices
Anle138b chemical structureDC10168

Anle138b

Anle138b is an aggregation-modulating research compound studied in α-synucleinopathies. Published mouse data connect reduced oligomer burden with neuronal and motor outcomes.

View activity & prices
CD437 chemical structureDC10491

CD437

CD437 is a retinoid-like research compound with direct DNA polymerase α inhibition and antiproliferative activity in cancer-cell models.

View activity & prices
KML-29 chemical structureDC10536

KML-29

KML-29 is a selective MAGL inhibitor used to investigate endocannabinoid metabolism, inflammatory pain and neuropathic pain.

View activity & prices
IDH-305 chemical structureDC10538

IDH-305

IDH-305 (IDH305) is an allosteric mutant-IDH1 inhibitor for studies of 2-hydroxyglutarate production and IDH1-mutant cancer biology.

View activity & prices
JTE-013 chemical structureDC10607

JTE-013

JTE-013 is an S1PR2 antagonist used in sphingosine-1-phosphate signaling, mitochondrial dynamics and fibrosis research.

View activity & prices
RGX-104 chemical structureDC10719

RGX-104

RGX-104 is an LXR agonist for studying myeloid-derived suppressor cells, ApoE signaling and tumor immune responses.

View activity & prices
PH-002 chemical structureDC10794

PH-002

PH-002 is an ApoE4 structure-correcting research compound studied in human iPSC-derived neurons with Alzheimer-related phenotypes.

View activity & prices
TAK-615 chemical structureDC10923

TAK-615

TAK-615 is an LPA1 negative allosteric modulator for receptor signaling and fibrosis-related pathway research.

View activity & prices
MC3343 chemical structureDC10940

MC3343

MC3343 is a nonnucleoside DNMT inhibitor for epigenetic reprogramming, osteoblastic differentiation and osteosarcoma research.

View activity & prices
BAY-3827 chemical structureDC10978

BAY-3827

BAY-3827 is an AMPK inhibitor with additional RSK-family activity, used to study metabolic signaling and androgen-dependent prostate cancer.

View activity & prices
LTX-401 chemical structureDC10988

LTX-401

LTX-401 is an amphipathic amino-acid derivative for cytolytic cell-death and local tumor-immunology research.

View activity & prices
MRL871 chemical structureDC11047

MRL871

MRL871 (MRL-871) is an allosteric RORγt ligand used in nuclear-receptor research. Independent work also identified PPARγ partial agonism.

View activity & prices
PF-543 chemical structureDC1107

PF-543

PF-543 is a potent, sphingosine-competitive SPHK1 inhibitor for investigating S1P production and sphingolipid signaling.

View activity & prices
OTS193320 chemical structureDC11256

OTS193320

OTS193320 is a SUV39H2 methyltransferase inhibitor for histone methylation, DNA-damage-response and cancer-cell research.

View activity & prices
OTS186935 chemical structureDC11257

OTS186935

OTS186935 is a SUV39H2 inhibitor with published cellular and xenograft activity, used in histone-methylation and cancer research.

View activity & prices
ABC 1183 chemical structureDC11299

ABC 1183

ABC 1183 (ABC1183) is a dual GSK-3/CDK9 inhibitor for cancer-cell proliferation and inflammatory signaling research.

View activity & prices
DO-264 chemical structureDC11464

DO-264

DO-264 (DO264) is an ABHD12 inhibitor for lysophosphatidylserine metabolism and immune-lipid signaling research.

View activity & prices
CK-869 chemical structureDC11475

CK-869

CK-869 is an Arp2/3 complex inhibitor for branched-actin and cytoskeletal research, with reported microtubule-related off-target effects.

View activity & prices
CLP257 chemical structureDC11507

CLP257

CLP257 is a neuronal chloride-signaling research compound originally reported as a KCC2 enhancer. Subsequent work challenged direct KCC2 activation and reported GABAA receptor potentiation.

View activity & prices
CB-002 chemical structureDC11669

CB-002

CB-002 (CB002) is a p53-pathway-restoring research compound studied in colorectal cancer cells and apoptosis signaling.

View activity & prices
9-ING-41 chemical structureDC11827

9-ING-41

9-ING-41 (Elraglusib) is a cancer-research compound originally developed as a GSK-3β inhibitor. Published work documents model-dependent growth inhibition and additional mechanisms.

View activity & prices
JP-153 chemical structureDC11954

JP-153

JP-153 is a focal-adhesion-signaling modulator for VEGF-dependent retinal endothelial-cell and angiogenesis research.

View activity & prices
MK-8722 chemical structureDC12020

MK-8722

MK-8722 is a direct allosteric activator of mammalian AMPK complexes for metabolic signaling and glucose-homeostasis research.

View activity & prices
STM2457 chemical structureDC53045

STM2457

STM2457 is a catalytic METTL3 inhibitor for RNA methylation, leukemia-cell differentiation and cancer research.

View activity & prices

Cart

Request quotation